Last chance to COVER UNDER $25!
Lilly to PAY UPFRONT PLUS ROYALITIES!
Under the terms of the agreement, Alkermes (NASDAQ: ALKS - News) will receive funding for product and process development activities and upfront and milestone payments. Lilly will have exclusive worldwide rights to products resulting from the collaboration and will pay Alkermes royalties based on product sales.
All POSITIVE NEWS out and the SHORTS & penny pinchers that missed out are whinning sell all the way from $10 to $25 on the way to $30!! HA! These are all BIG TIME DRUGS partnered with BIG TIME PHARMA'S.Wake up and quit looking where it's been and look where it's GOING!!!!.....Up,UP,UP!